Antibodies to Coxsackie B viruses in congestive cardiomyopathy

Insights

Coxsackie B virus infection may contribute to congestive cardiomyopathy, especially in patients with a short symptom history and preceding fever. Further research is needed to understand viral mechanisms of myocardial damage.

Area of Science:

  • Cardiology
  • Virology
  • Pathology

Background:

  • Congestive cardiomyopathy is a significant cardiac condition with multifactorial causes.
  • The role of viral infections, particularly Coxsackie B virus, in the pathogenesis of cardiomyopathy remains under investigation.

Purpose of the Study:

  • To investigate the association between previous Coxsackie B virus infection and the development of congestive cardiomyopathy.
  • To explore correlations between viral titres, symptom duration, and clinical presentation in patients with cardiomyopathy.

Main Methods:

  • A case-control study comparing 50 patients with congestive cardiomyopathy to age- and sex-matched controls.
  • Serological testing for Coxsackie B virus neutralisation titres.
  • Analysis of symptom history, including onset and duration.
  • Endomyocardial biopsies in a subset of patients to assess for myocarditis and viral presence.

Main Results:

  • Higher Coxsackie B virus neutralisation titres were observed more frequently in control subjects than in patients with cardiomyopathy.
  • Elevated titres were more common in patients with a symptomatic history of 1 year or less.
  • A history of febrile illness at symptom onset was associated with higher viral titres.
  • Endomyocardial biopsies did not reveal evidence of active myocarditis or viral involvement in the examined cases.

Conclusions:

  • The findings suggest a complex and potentially indirect role for Coxsackie B virus in congestive cardiomyopathy.
  • While direct viral causation was not confirmed by biopsy, circumstantial evidence supports a link, particularly in acute presentations.
  • Further research is warranted to elucidate the mechanisms of Coxsackie B virus-induced myocardial damage.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...